Short-term and Long-term Causes of Death in Patients With Alcoholic Hepatitis in Denmark

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 10, 2014, Pages 1739-1744.e1

  Orntoft, Nikolaj Worm ^a   Sandahl, Thomas Damgaard ^a   Jepsen, Peter ^a   Vilstrup, Hendrik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Alcohol Associated Hepatitis; Alcoholic Liver Disease; Epidemiology; Variceal Hemorrhage

Indexed keywords

ADULT; ALCOHOL ABUSE; ALCOHOL INTOXICATION; ALCOHOL LIVER DISEASE; ARTICLE; BLEEDING; CANCER MORTALITY; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; COLON CANCER; DENMARK; DISEASE PREDISPOSITION; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HEART ARREST; HEPATORENAL SYNDROME; HOSPITAL ADMISSION; HUMAN; INFECTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RECURRENCE RISK; RECURRENT DISEASE; RESPIRATORY ARREST; SUICIDE; VARICEAL HEMORRHAGE; COHORT ANALYSIS; COMMUNICABLE DISEASES; COMPLICATION; MIDDLE AGED; MORTALITY;

CAUSE OF DEATH; COHORT STUDIES; COMMUNICABLE DISEASES; DENMARK; FEMALE; HEPATITIS, ALCOHOLIC; HUMANS; LIVER FAILURE; MALE; MIDDLE AGED;

EID: 84908088067     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.04.020     Document Type: Article

References (24)

1. Sandahl T.D., Jepsen P., Thomsen K.L., et al. Incidence and mortality of alcoholic hepatitis in Denmark 1999-2008: a nationwide population based cohort study. JHepatol 2011, 54:760-764.
2. Lucey M.R., Mathurin P., Morgan T.R. Alcoholic hepatitis. NEngl J Med 2009, 360:2758-2769.
3. Forrest E.H., Evans C.D., Stewart S., et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut 2005, 54:1174-1179.
4. Andersen T.F., Madsen M., Jorgensen J., et al. The Danish National Hospital Register: a valuable source of data for modern health sciences. Dan Med Bull 1999, 46:263-268.
5. Sandahl T.D., Jepsen P., Ott P., et al. Validation of prognostic scores for clinical use in patients with alcoholic hepatitis. Scand J Gastroenterol 2011, 46:1127-1132.
6. Vestberg K., Thulstrup A.M., Sorensen H.T., et al. Data quality of administratively collected hospital discharge data for liver cirrhosis epidemiology. JMed Syst 1997, 21:11-20.
7. Satagopan J.M., Ben-Porat L., Berwick M., et al. Anote on competing risks in survival data analysis. Br J Cancer 2004, 91:1229-1235.
8. Sidhu S.S., Goyal O., Singla P., et al. Corticosteroid plus pentoxifylline is not better than corticosteroid alone for improving survival in severe alcoholic hepatitis (COPE trial). Dig Dis Sci 2012, 57:1664-1671.
9. Coffin P.O., Sharpe B.A. Cause of death in alcoholic hepatitis. JHosp Med 2007, 2:51-52.
10. Nguyen-Khac E., Thevenot T., Piquet M.A., et al. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. NEngl J Med 2011, 365:1781-1789.
11. Potts J.R., Goubet S., Heneghan M.A., et al. Determinants of long-term outcome in severe alcoholic hepatitis. Aliment Pharmacol Ther 2013, 38:584-595.
12. Frank L. Epidemiology: when an entire country is a cohort. Science 2000, 287:2398-2399.
13. Sorensen H.T. Regional administrative health registers as a resource in clinical epidemiology. Int J Risk Saf Med 1997, 10:1-22.
14. Mabeck C.E., Wichmann B. [Causes of death and death certificates: an evaluation of the diagnosis in 373 death certificates]. Ugeskrift for laeger 1980, 142:257-261.
15. Verma S., Ajudia K., Mendler M., et al. Prevalence of septic events, type 1 hepatorenal syndrome, and mortality in severe alcoholic hepatitis and utility of discriminant function and MELD score in predicting these adverse events. Dig Dis Sci 2006, 51:1637-1643.
16. Helman R.A., Temko M.H., Nye S.W., et al. Alcoholic hepatitis: natural history and evaluation of prednisolone therapy. Ann Intern Med 1971, 74:311-321.
17. Mathurin P., Lucey M.R. Management of alcoholic hepatitis. JHepatol 2012, 56(Suppl 1):S39-S45.
18. Liangpunsakul S. Clinical characteristics and mortality of hospitalized alcoholic hepatitis patients in the United States. JClin Gastroenterol 2011, 45:714-719.
19. Louvet A., Wartel F., Castel H., et al. Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor. Gastroenterology 2009, 137:541-548.
20. Diehl A.M. Alcoholic liver disease: natural history. Liver Transpl Surg 1997, 3:206-211.
21. Bird G.L., Williams R. Factors determining cirrhosis in alcoholic liver disease. Mol Aspects Med 1988, 10:97-105.
22. Sorensen T.I., Orholm M., Bentsen K.D., et al. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 1984, 2:241-244.
23. Mathurin P., Duchatelle V., Ramond M.J., et al. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 1996, 110:1847-1853.
24. Potts J.R., Howard M.R., Verma S. Recurrent severe alcoholic hepatitis: clinical characteristics and outcomes. Eur J Gastroenterol Hepatol 2013, 25:659-664.